Form 8-K - Current report:
SEC Accession No. 0001193125-26-109407
Filing Date
2026-03-17
Accepted
2026-03-17 08:00:07
Documents
11
Period of Report
2026-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20260316.htm   iXBRL 8-K 44748
2 EX-99.1 hcwb-ex99_1.htm EX-99.1 20012
3 GRAPHIC img90053791_0.gif GRAPHIC 15446
  Complete submission text file 0001193125-26-109407.txt   197093

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20260316.xsd EX-101.SCH 24849
14 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20260316_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 26759129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)